Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Yung Ta Kao"'
Autor:
Chang-Ying Chen, Wang Mei-Tzu, Shih-Hsien Sung, Yih-Jer Wu, Chih-Hsin Hsu, Wan-Jing Ho, Yen-Hung Lin, Wei-Shin Liu, Ju-Chi Liu, Yung-Ta Kao, Wen-Shiann Wu, Chun-Hsien Wu, Meng-Huan Lei, Yu-Wei Chen, Chien Chen-Yu, Yu-Wei Chiu, Zen-Kong Dai, Tsung-Hsien Lin, Lin Lin, Cheng-Chih Chung, Chang-Min Chung, Sung-Hao Huang, Chin-Chang Cheng, Yen-Wen Wu, Ting-Hsing Chao, Juey-Jen Hwang, Charles Jia-Yin Hou, Wei-Chun Huang
Publikováno v:
Heliyon, Vol 10, Iss 6, Pp e27537- (2024)
Background: Demographics of pulmonary hypertension (PH) has changed a lot over the past forty years. Several recent registries noted an increase in mean age of PH but only a few of them investigated the characteristics of elderly patients. Thus, we a
Externí odkaz:
https://doaj.org/article/3617e83f27264f938d9f3a483f06b3d0
Autor:
Chun-Hsu Pan, Shu-Chen Chien, Chang-Jui Chen, Chun-Ming Shih, Ming-Hsiung Hsieh, Chun-Yao Huang, Wei-Fung Bi, Chao-Shun Chan, Yung-Ta Kao, Cheng-Yi Hsiao, Shuo-Ju Chiang, Kuang-Hsing Chiang, Jen-Hung Huang, Yun-Ru Liu, Ji-Dung Luo, Hui-Yu Huang, Chieh-Hsi Wu
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Patients who receive percutaneous coronary intervention (PCI) have different chances of developing in-stent restenosis (ISR). To date, no predictable biomarker can be applied in the clinic. MicroRNAs (miRNAs or miRs) play critical
Externí odkaz:
https://doaj.org/article/28b563f3da134c64b478cb0c6cfb6513
Publikováno v:
The American Journal of Cardiology. 198:56-63
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2483371b18e04c0c39388e6937feba9e
https://doi.org/10.1016/j.amjcard.2023.03.035
https://doi.org/10.1016/j.amjcard.2023.03.035
Autor:
Yi-Cheng Lin, Bi-Li Chen, Chun-Ming Shih, Feng-Yen Lin, Chih-Wei Chen, Chien-Yi Hsu, Yung-Ta Kao, Wei-Fung Bi, Li-Ying Chen, Li-Nien Chien, Te-Chao Fang, Chun-Yao Huang
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0249940 (2021)
BackgroundThe optimal anticoagulant for end-stage renal disease patients for stroke prophylaxis is unknown. The efficacy and safety of warfarin in this population are debatable. In addition, real-world evidence of direct oral anticoagulants in patien
Externí odkaz:
https://doaj.org/article/c4fbd86b60a5438eb9b6f790be83955b
Autor:
Yung-Ta Kao, Yi-Chen Hsieh, Chien-Yi Hsu, Chun-Yao Huang, Ming-Hsiung Hsieh, Yung-Kuo Lin, Jong-Shiuan Yeh
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0229186 (2020)
Acute coronary syndrome (ACS) patients with diabetes have significantly worse cardiovascular outcomes than those without diabetes. This study aimed to compare the performance of The Thrombolysis In Myocardial Infarction (TIMI), Global Registry of Acu
Externí odkaz:
https://doaj.org/article/d3d68294955a4160a938bc499aa0c52e
BACKGROUND Atrial fibrillation (AF) is an independent risk factor that increases the risk of stroke fivefold. The purpose of our study was to develop an AF predictive model by machine learning (ML) based on 3-year medical information without electroc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6376e9a041702955fd0325ec1aec5ead
https://doi.org/10.2196/preprints.39738
https://doi.org/10.2196/preprints.39738
Autor:
Kuang-Hsing Chiang, Wan-Li Cheng, Chun-Ming Shih, Yi-Wen Lin, Nai-Wen Tsao, Yung-Ta Kao, Chih-Ting Lin, Shinn-Chih Wu, Chun-Yao Huang, Feng-Yen Lin
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0136405 (2015)
Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, are used to reduce cholesterol biosynthesis in the liver. Accordingly, statins regulate nitric oxide (NO) and glutamate metabolism, inflammation, angiogenesis, immunity
Externí odkaz:
https://doaj.org/article/919570a7956144a5a29432cb7957a42b
Autor:
Chieh Hsi Wu, Chun Hsu Pan, Chun Yao Huang, Jen Hung Huang, Chang Jui Chen, Cheng Yi Hsiao, Kuang Hsing Chiang, Wei Fung Bi, Ming Hsiung Hsieh, Yung Ta Kao, Ji Dung Luo, Shuo Ju Chiang, Yun Ru Liu, Hui Yu Huang, Shu Chen Chien, Chun Ming Shih, Chao Shun Chan
Publikováno v:
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-7 (2021)
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-7 (2021)
Background Patients who receive percutaneous coronary intervention (PCI) have different chances of developing in-stent restenosis (ISR). To date, no predictable biomarker can be applied in the clinic. MicroRNAs (miRNAs or miRs) play critical roles in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53bffd5ea8ebe6ab29b01e8d09439fa7
https://pubmed.ncbi.nlm.nih.gov/33557763
https://pubmed.ncbi.nlm.nih.gov/33557763
Autor:
Kang-Ling, Wang, Yung-Ta, Kao, Wei-Tien, Chang, Hsien-Yuan, Chang, Wei-Chun, Huang, Po-Chao, Hsu, Chih-Hsin, Hsu, Chien-Lung, Huang, Li-Chuan, Hsieh, Chi-Yen, Wang, Yen-Hung, Lin, Tsung-Hsien, Lin, Kuan-Ming, Chiu, Juey-Jen, Hwang, Pao-Hsien, Chu
Publikováno v:
Acta Cardiol Sin
Pulmonary embolism (PE) is a potential life-threatening condition and risk-adapted diagnostic and therapeutic management conveys a favorable outcome. For patients at high risk for early complications and mortality, prompt exclusion or confirmation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::45e83069a1fe00e625c1b0f35b989368
https://pubmed.ncbi.nlm.nih.gov/33235412
https://pubmed.ncbi.nlm.nih.gov/33235412
Publikováno v:
Acta Cardiol Sin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::409da2bcee2debd51ed1ba242779c60d
https://pubmed.ncbi.nlm.nih.gov/32952361
https://pubmed.ncbi.nlm.nih.gov/32952361